Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Guardian Capital LP
Guardian Capital LP boosted its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 8.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,676 shares of the medical equipment provider’s stock after buying an additional 580 shares during the quarter. Guardian Capital LP’s holdings in Zimmer Biomet Holdings were worth $986,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. BlackRock Inc. lifted its position in Zimmer Biomet Holdings by 4.1% during the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock worth $2,236,657,000 after acquiring an additional 679,080 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Zimmer Biomet Holdings by 2.6% during the second quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock valued at $1,718,057,000 after acquiring an additional 339,106 shares during the period. State Street Corp boosted its holdings in Zimmer Biomet Holdings by 2.4% during the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock valued at $1,000,463,000 after acquiring an additional 191,747 shares during the period. Longview Partners Guernsey LTD boosted its holdings in Zimmer Biomet Holdings by 4.4% during the second quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock valued at $818,898,000 after acquiring an additional 269,184 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in Zimmer Biomet Holdings by 25.0% during the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock valued at $602,159,000 after acquiring an additional 987,398 shares during the period. Institutional investors and hedge funds own 85.36% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Guardian Capital LP” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/zimmer-biomet-holdings-inc-zbh-shares-bought-by-guardian-capital-lp/1603269.html.
A number of equities analysts have recently commented on ZBH shares. Stifel Nicolaus reiterated a “hold” rating and issued a $125.00 price objective on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Gabelli initiated coverage on Zimmer Biomet Holdings in a research note on Thursday, August 24th. They set a “buy” rating and a $142.00 target price for the company. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 8th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Monday. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Zimmer Biomet Holdings presently has an average rating of “Hold” and an average price target of $136.55.
In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.07% of the company’s stock.
Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded up 0.35% during mid-day trading on Monday, reaching $117.50. The company had a trading volume of 136,868 shares. The firm’s 50 day moving average is $114.50 and its 200-day moving average is $120.75. Zimmer Biomet Holdings, Inc. has a 12-month low of $95.63 and a 12-month high of $133.49. The stock has a market capitalization of $23.76 billion, a P/E ratio of 33.47 and a beta of 1.19.
Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same period in the prior year, the business posted $2.02 earnings per share. The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, analysts expect that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.
Zimmer Biomet Holdings Company Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.